Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring BRAF mutations.
Wang H, Cheng L, Zhao C, Zhou F, Jiang T, Guo H, Shi J, Chen P, Tang Z, Mao S, Jia K, Ye L, Cai C, Li X, Chen X, Zhou C.
Wang H, et al. Among authors: zhou f, zhou c.
Transl Lung Cancer Res. 2023 Feb 28;12(2):219-229. doi: 10.21037/tlcr-22-613. Epub 2023 Feb 25.
Transl Lung Cancer Res. 2023.
PMID: 36895926
Free PMC article.